Health · Public Health & Disease · 2 hrs ago
Baltimore ERs see more visits linked to unsupervised GLP-1 use
Baltimore emergency departments are seeing more visits linked to GLP-1 drugs.
Emergency physician Miriam Fischer of MedStar Health said the visits are often preventable.
Some patients are buying the medications online and using them without medical supervision.
The source does not specify which side effects are bringing patients to emergency rooms.
GLP-1 medications are the drugs at the center of the reported rise in visits.
The increase matters because these visits may be avoidable with medical oversight.
No next steps or planned response were described.
Emergency physicians in Baltimore are seeing a rise in preventable emergency room visits linked to GLP-1 medications.
The visits are tied to people buying the medications online and using them without medical supervision.
Miriam Fischer, an emergency medicine physician at MedStar Health, told WBAL-TV about the trend.
The report was published by WBAL-TV on Nov. 10.
- Who
- Baltimore emergency physicians and people using GLP-1 medications without medical supervision.
- What
- Emergency physicians are seeing a rise in preventable ER visits linked to GLP-1 medications.
- When
- Reported Nov. 10; the article was published Nov. 11, 2026.
- Where
- Baltimore, Maryland.
- Why
- More people are buying GLP-1 medications online and using them without medical supervision.
This story does not have two clearly opposing sides.
WBAL-TV reported that Baltimore emergency physicians were seeing a rise in preventable ER visits linked to GLP-1 medications.
Becker's Hospital Review published its article about the reported rise.
- Location
- Baltimore
- Medication
- GLP-1 medications
- Trend
- Rise in preventable ER visits
- Reported cause
- Online purchases and use without medical supervision
- Physician
- Miriam Fischer, emergency medicine physician at MedStar Health